Mastronarde J G, Monick M M, Hunninghake G W
Division of Pulmonary, Critical Care and Occupational Medicine, University of Iowa College of Medicine, Iowa City, USA.
Am J Respir Cell Mol Biol. 1995 Aug;13(2):237-44. doi: 10.1165/ajrcmb.13.2.7626291.
Respiratory syncytial virus (RSV) is an important respiratory pathogen that preferentially infects epithelial cells in the airway, and causes a local inflammatory response. Although it has been previously demonstrated that RSV-infected airway epithelial produce cytokines, including interleukin-8 (IL-8), which contributes to the inflammatory response, the regulation of this effect of RSV is unknown. To further characterize the mechanisms by which RSV infection triggers release of IL-8, we first exposed cultured A549 cells to RSV, and measured IL-8 release via enzyme-linked immunosorbent assays (ELISA), and IL-8 messenger RNA (mRNA) induction via Northern blot analysis. We observed a dose- and time-dependent release of IL-8 in response to RSV. The optimal dose of RSV was 10(4) TCID50/ml, and maximal release of IL-8 was measured at 72 to 96 h after infection. RSV induced a biphasic (early and late) increase in IL-8 mRNA. The early phase was independent of viral infection, whereas the more pronounced late phase required the presence of live virus and infection of the epithelium. Partial (< 50%) cytopathic effects were noted at 48 h and progressed to 75% at 96 h. The monolayer was still intact at 96 h. Inhibitors of nitric oxide, including NG-monomethyl-L-arginine (L-NMMA), NG-nitro-L-arginine methyl ester (L-NAME), and aminoguanidine had no effect on IL-8 release or IL-8 mRNA induction. We did, however, demonstrate a dose-dependent decrease in IL-8 release and IL-8 mRNA induction in RSV-infected epithelial treated with the antioxidants dimethyl sulfoxide (DMSO) or 5,5-dimethyl-1-pyrroline-N-oxide (DMPO). Peak effects were noted at a concentration of 2% DMSO and 50 microM DMPO. The antioxidants did not inhibit viral replication or infection. This data suggest that RSV-induced IL-8 production in airway epithelium is mediated via changes in oxidant tone. The data also suggest a potential therapeutic role for antioxidants in RSV infections.
呼吸道合胞病毒(RSV)是一种重要的呼吸道病原体,它优先感染气道中的上皮细胞,并引发局部炎症反应。尽管此前已经证明,受RSV感染的气道上皮会产生细胞因子,包括白细胞介素-8(IL-8),其有助于炎症反应,但RSV这种作用的调节机制尚不清楚。为了进一步阐明RSV感染触发IL-8释放的机制,我们首先将培养的A549细胞暴露于RSV,并通过酶联免疫吸附测定(ELISA)测量IL-8释放,通过Northern印迹分析测量IL-8信使核糖核酸(mRNA)的诱导情况。我们观察到,响应RSV时,IL-8呈剂量和时间依赖性释放。RSV的最佳剂量为10(4) TCID50/ml,感染后72至96小时测量到IL-8的最大释放量。RSV诱导IL-8 mRNA出现双相(早期和晚期)增加。早期阶段与病毒感染无关,而更明显的晚期阶段需要活病毒的存在以及上皮细胞的感染。48小时时观察到部分(<50%)细胞病变效应,96小时时进展到75%。96小时时单层细胞仍然完整。一氧化氮抑制剂,包括NG-单甲基-L-精氨酸(L-NMMA)、NG-硝基-L-精氨酸甲酯(L-NAME)和氨基胍,对IL-8释放或IL-8 mRNA诱导没有影响。然而,我们确实证明,在用抗氧化剂二甲基亚砜(DMSO)或5,5-二甲基-1-吡咯啉-N-氧化物(DMPO)处理的受RSV感染的上皮细胞中,IL-8释放和IL-8 mRNA诱导呈剂量依赖性降低。在2% DMSO和50 microM DMPO的浓度下观察到峰值效应。抗氧化剂不抑制病毒复制或感染。这些数据表明,RSV诱导气道上皮细胞产生IL-8是通过氧化还原状态的变化介导的。这些数据还表明抗氧化剂在RSV感染中具有潜在的治疗作用。